Heron Therapeutics CEO Craig Collard receives $11M in 2023
Heron Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Heron Therapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, five executives at Heron Therapeutics received on average a compensation package of $3.9M, a 194% increase compared to previous year.
Average pay of disclosed executives at Heron Therapeutics
Craig Collard, Chief Executive Officer, received $11M in total. 86% of Collard's compensation, or $9.3M, was in option awards. Collard also received $327K in non-equity incentive plan, $493K in salary, $547K in stock awards, as well as $152K in other compensation.
Barry D. Quart, Chief Executive Officer, received a compensation package of $4M, which increased by 252% compared to previous year. 40% of the compensation package, or $1.6M, was in option awards.
David Szekeres, Executive Vice President, Chief Commercial Officer, earned $1.9M in 2023, a 31% increase compared to previous year.
Ira Duarte, Chief Financial Officer, received $1.5M in 2023.
William Forbes, Chief Development Officer, earned $1.5M in 2023.
Related executives
Craig Collard
Heron Therapeutics
Chief Executive Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
You may also like
Source: SEC filing on April 29, 2024.